Brussels/Luxembourg
24 June 2005
The Environment
Council voted today on a package of proposals from the
Commission concerning genetically modified organisms (GMOs). The
proposals require the lifting of bans or restrictions (so-called
national safeguard clauses) imposed by Austria, France, Germany,
Greece and Luxembourg on 8 authorised GM products. The Council
voted against all 8 Commission proposals. This is the first time
that Council found a qualified majority against a Commission
proposal on GMOs. It is thus a new situation in terms of
subsequent action. The Commission will have to carefully
consider the legal and scientific bases that underpin any
further proposals, as well as the implications for EU internal
market and trading partners. In a separate proposal involving
the authorisation of placing MON863 maize on the European market
for import, processing and feed use, the Council did not find
the required qualified majority for or against. This case will
now go back to the Commission for a final decision.
Stavros Dimas,
Commissioner for the Environment, said, "The Commission has a
legal obligation to make sure that the existing regulatory
framework governing the release of GMOs is correctly applied by
Member States. That is why we proposed to lift the current bans
or restrictions on certain GMOs in Austria, France, Germany,
Greece and Luxemburg. The fact that the Council rejected all 8
proposals raises a host of questions. What is certain is that
today’s vote sends a political signal that Member States may
want to revisit some aspects of the existing system.”
The Commission now
has three options: to re-submit the existing proposals back to
the Council, to amend the proposals and submit to the Council,
or to present a legislative proposal on the basis of the Treaty.
Commissioner Dimas said that the Commission will now reflect on
all legal and scientific aspects related to the 8 decisions in
order to decide on the best way forward.
Background on
safeguard clauses
The proposals to
lift the so-called “national safeguard measures” on certain
authorised genetically modified organisms concern the GM maize
varieties T25 and MON810 banned in Austria, GM maize Bt176
banned in Austria, Germany and Luxembourg, the oilseed rape
varieties MS1xRF1 banned in France and Topas 19/2 banned in
France and Greece (see table in annex).
A number of these
eight safeguard clauses include bans or restrictions on
cultivation whilst others include bans on import and use in food
and feed. The responsible Scientific Committees deemed that the
information submitted by the Member States as justification for
the bans did not change the original risk assessments which had
been carried out as part of the authorisation process.
In December 2003,
then Environment Commissioner Margot Wallström submitted letters
to the above Member States requesting that they re-consider
their safeguard clauses in view of the new regulatory framework
and if necessary, to re-submit them under Article 23 of
Directive 200/18/EC on the deliberate release of GMOs in the
environment (which replaced Directive 90/220/EEC). In view of
this request, Greece and Austria submitted, in the first quarter
of 2004, further information in support of their bans but no
response was received from the other Member States.
This additional
information potentially impacted on all eight cases and was
submitted to EFSA for opinion. In its opinion of July 2004, EFSA
concluded, as for all previous arguments and information, that
the additional information did not invalidate the original risk
assessments for the GMOs in question. Consequently, the
Commission was required to submit draft decisions, initially to
the Regulatory Committee, requesting the Member States concerned
to lift their national safeguard measures.
The Regulatory
Committee composed of Member States representatives, on 29
November 2004, failed to reach qualified majority either in
favour or against any of these draft decisions. Draft proposals
were subsequently transmitted, on 26/27 April 2005, to the
Council for opinion.
Background on
MON 863
A request to
market a genetically modified maize product (line MON863), with
resistance to corn rootworm, was submitted by Monsanto to the
competent authority of Germany for assessment. The requested
uses of the product included import, processing and feed use but
not use in food or for cultivation.
The German
competent authority concluded that there was no scientific
evidence that indicated any risk for human health or the
environment for the requested uses. However, other Member States
raised and maintained objections in terms of molecular
characterisation, allergenicity, toxicity, an inadequate
monitoring plan, accidental spillage, presence of an antibiotic
resistance marker gene and detectability. The European Food
Safety Authority (EFSA) was consulted and delivered its opinion
on 16 April 2004 concluding that the MON863 maize was as safe as
conventional oilseed rape and unlikely to produce adverse
effects.
Consequently, a
draft Commission Decision to place the product on the market was
presented to the Regulatory Committee for vote on 20 September
2004. However, on 17 September 2004, the German competent
authority submitted to the Commission and to the Member States,
a re-evaluation of a rat-feeding study included in the original
application.
Many Member States
expressed concerns in terms of reaching a formal position in the
Regulatory Committee meeting, pending an examination of this
re-evaluation and consequently, no formal vote took place at
this time. Following the meeting, EFSA was requested to evaluate
the impact of the conclusions of the re-evaluated rat study on
the original risk assessment concluded that it did not put into
question its initial opinion on this product.
The Regulatory
Committee was re-convened on 29 November 2004. The Committee,
acting by qualified majority, did not deliver an opinion. The
Commission consequently submitted a draft Proposal to the
Council.
Further
information on the regulation on GMOs in the European Union can
be found at:
MEMO/05/104
Member State and date of invocation
|
Product details and date of Scientific
Opinion concerning original information to
justify bans
|
|
Additional information and date of reception
|
|
Swede rape resistant to glufosinate MS1/RF1
Uses: cultivation for breeding activities (seed
production)
Product approval: 1996
Scientific Committee Opinion: 18.05.99
|
Negative effects on human health, the
environment and agriculture;
Clarification issues re dissemination,
volunteers, gene flow and accumulation of
resistance genes
|
FR: 16.02.04 (holding reply); 27.08.04
renewal of prohibition until 17.10.06
|
2. AU (14.02.97)
3. LX (17.03.97)
4. DE (28.02.00)
|
Bt-maize tolerant to glufosinate ammonium
(Bt-176)
Uses: All uses (cultivation, food and feed,
processing)
Product approval: 1997
Scientif. Committees Opinion:
21.03., 10.04., 12.05.97 (AU); 09.11.00 (DE)
EFSA: 08.07.04 (AU)
|
Effects of BT-toxins on non-target organisms and
development of resistance to toxins by target
organisms
Risks associated with ampicillin antibiotic
resistance market gene
|
AU: 09.01, 09.02, 17.02.04
Information concerning potential environmental
impact of Bt-toxin and allergenic and
toxicological risk assessment
LUX: 19.05.2004
Information concerning potential environmental
impact of Bt-toxin and antibiotic resistance
genes as well as allergenic and toxicological
risk assessment
|
5. EL (05.11.98)
6. FR (20.11.98)
|
Swede rape tolerant to glufosinate (Topas
19/2)
Uses: import, storage and processing (no
cultivation)
Product approval: 1998
Scientific Committee Opinion: 18.05.99
EFSA: 08.07.04 (EL)
|
Issues concerning dissemination, persistence,
volunteers and gene flow in the environment
(arising from spillage or unintended release)
|
FR: 16.02.04 (holding reply); 27.08.04
renewal of prohibition until 17.10.06
EL: 05.03.04
Information concerning environmental risks,
consu-mer protection and co-existence
(out-crossing with wild relatives, which are
consumed by humans in Greece; enhanced
capability of rape, wild relatives and hybrids
to survive/spread, potential for multi-resistant
wild plants and weeds)
|
|
Maize expressing the Bt cryIA(b) gene
(MON 810)
Uses: All uses (cultivation, food and feed,
processing)
Product approval: 1998
Scientific Committee Opinion: 24.09.99
EFSA: 08.07.04
|
Effects of BT-toxins on non-target organisms and
development of resistance to toxins by target
organisms
|
AU: 09.01, 09.02, 17.02.04
Information concerning potential environmental
impact of Bt-toxin and allergenic and
toxicological risk assessment
|
|
Maize tolerant to glufosinate (T25)
Uses: All uses (cultivation, food and feed,
processing)
Product approval: 1998
Scientific Committee Opinion: 30.11.00 (AU)
replaced 20.07.01
EFSA: 08.07.04
|
Risk of out-crossing with wild relatives and
conventional crops as well as in sensitive areas
No monitoring
|
AU: 09.01., 09.02., 17.02.04
Information concerning allergenic and
toxicological risk assessment.
|
|